πŸ‡ΊπŸ‡Έ FDA
Patent

US 7547686

Combretastatin A-3 prodrug

granted A61KA61K31/66A61P

Quick answer

US patent 7547686 (Combretastatin A-3 prodrug) held by ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/66, A61P, A61P31/00, A61P35/00